ISOPTO ATROPINE- atropine sulfate solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

isopto atropine- atropine sulfate solution

alcon laboratories, inc. - atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - atropine sulfate 10 mg in 1 ml - isopto® atropine 1% is indicated for: atropine sulfate ophthalmic solution should not be used in anyone who has demonstrated a previous hypersensitivity or known allergic reaction to any ingredient of the formulation because it may recur. risk summary there are no adequate and well-controlled studies with isopto® atropine 1% administration in pregnant women to inform a drug-associated risk. adequate animal development and reproduction studies have not been conducted with atropine sulfate. in humans, 1% atropine sulfate is systemically bioavailable following topical ocular administration [see clinical pharmacology (12.3)] . isopto® atropine 1% should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. there is no information to inform risk regarding the presence of atropine in human milk following ocular administration of isopto® atropine 1% to the mother. the effects on breastfed infants and the effects on milk production are also unknown.  the developmental a

ISOPTO CARPINE- pilocarpine hydrochloride solution/ drops Stany Zjednoczone - angielski - NLM (National Library of Medicine)

isopto carpine- pilocarpine hydrochloride solution/ drops

alcon laboratories, inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 10 mg in 1 ml - isopto® carpine is indicated for the:         none. pregnancy. category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. isopto® carpine should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when isopto® carpine is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

isopto cetamide- sulfacetamide sodium solution/ drops
cetamide- sulfacetamide sodium ointment Stany Zjednoczone - angielski - NLM (National Library of Medicine)

isopto cetamide- sulfacetamide sodium solution/ drops cetamide- sulfacetamide sodium ointment

alcon - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - solution/ drops - 150 mg in 1 ml - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus ( viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa. a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation.

ISOPTO TEARS- hypromellose 2910 solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

isopto tears- hypromellose 2910 solution

alcon laboratories, inc. - hypromellose 2910 (4000 mpa.s) (unii: rn3152op35) (hypromellose 2910 (4000 mpa.s) - unii:rn3152op35) - lubricant uses - for the temporary relief of burning and irritation due to dryness of the eye. - for use as a protectant against further irritation. stop use and ask a doctor if - you experience eye pain - you experience changes in vision - you experience continued redness or irritation - the condition worsens or persists for more than 72 hours